Drug companies may provide information directly to EU patients
European parliament has passed draft legislation to allow drug companies to provide information directly to patients. The draft legislation would enable patients in the EU to receive data on a drug’s characteristic and the disease and condition for which it is designed. It claims to guarantee that the information provided would not stray into advertising. EU Governments have to approve this legislation before it can take effect.
BMJ 2010, 341, c6883